Outcome
    Moderate Evidence

    Chromium Picolinate for Cholesterol Management

    Lipid effects of chromium are small and not consistently reproduced.

    Overview

    Lipid effects of chromium are small and not consistently reproduced.

    Verdict

    Insufficient evidence

    How It Works

    Insulin sensitisation could indirectly influence hepatic lipoprotein handling.

    Dosing & Protocol

    Typical dose

    Recommended dose
    200-1000 mcg/day was studied; not recommended for lipids
    Expected timeframe
    Not established - no reliable lipid effect

    Protocol

    studied dose
    200-1000 mcg/day of chromium picolinate, with lipids usually a secondary endpoint in diabetes trials
    evidence note
    Verdict is insufficient - chromium is not a lipid treatment
    what happened
    Individual trials report occasional small HDL increases or triglyceride reductions, but pooled analyses do not support a clinically meaningful lipid effect. LDL cholesterol, the target that matters most for cardiovascular risk, does not respond
    what actually works
    For LDL: soluble fibre, plant sterols, weight loss and statins. For triglycerides: alcohol reduction, refined carbohydrate reduction, weight loss and prescription omega-3
    if you take it for glucose
    200-400 mcg/day with meals is reasonable; simply do not expect lipid change

    Evidence

    What the studies say

    Trials report occasional small HDL increases or triglyceride reductions, but pooled analyses do not support a clinically meaningful lipid effect.

    No studies are yet linked to both Chromium Picolinate and Cholesterol Management.

    Safety

    Caveats

    Do not use chromium in place of proven lipid management, particularly with established cardiovascular disease or a high calculated risk. Keep to 1000 mcg/day or less; case reports at high chronic doses include kidney failure, hepatotoxicity and rhabdomyolysis. Avoid in kidney or liver disease. Additive hypoglycaemia with diabetes medication. Antacids reduce absorption; caution with levothyroxine and NSAIDs. Avoid high-dose use in pregnancy and breastfeeding.

    Less likely to help if

    Essentially everyone for lipid outcomes - no subgroup shows a consistent, clinically meaningful effect.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.